{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:51:47Z","timestamp":1792605107136,"version":"4.5.0"},"publisher-location":"Cham","reference-count":121,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030055417","type":"print"},{"value":"9783030055424","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-3-030-05542-4_14","type":"book-chapter","created":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T02:38:30Z","timestamp":1549939110000},"page":"271-293","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Metabolomic Biomarkers in Mental Disorders: Bipolar Disorder and Schizophrenia"],"prefix":"10.1007","author":[{"given":"Melissa","family":"Quintero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danijela","family":"Stanisic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o G. M.","family":"Pontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00e1ssia Brena Barroso Carneiro","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ljubica","family":"Tasic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,13]]},"reference":[{"key":"14_CR1","first-page":"471","volume":"13","author":"H Venigalla","year":"2017","unstructured":"Venigalla H, Mekala HM, Hassan M, Zain H (2017) An update on biomarkers in psychiatric disorders\u2014are we aware, do we use in our clinical practice? Ment Health Fam Med 13:471\u2013479","journal-title":"Ment Health Fam Med"},{"issue":"2","key":"14_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1503\/jpn.130018","volume":"38","author":"P Boksa","year":"2013","unstructured":"Boksa P (2013) A way forward for research on biomarkers for psychiatric disorders. J Psychiatry Neurosci 38(2):75\u201377","journal-title":"J Psychiatry Neurosci"},{"issue":"1","key":"14_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0165-0327(87)90056-5","volume":"12","author":"A Gjerris","year":"1987","unstructured":"Gjerris A, S\u00f8rensen AS, Rafaelsen OJ, Werdelin L, Alling C, Linnoila M (1987) 5-HT and 5-HIAA in cerebrospinal fluid in depression. J Affect Disord 12(1):13\u201322","journal-title":"J Affect Disord"},{"issue":"3","key":"14_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0006-3223(00)00825-8","volume":"48","author":"RG Ross","year":"2000","unstructured":"Ross RG, Olincy A, Harris JG, Sullivan B, Radant A (2000) Smooth pursuit eye movements in schizophrenia and attentional dysfunction: adults with schizophrenia, ADHD, and a normal comparison group. Biol Psychiatry 48(3):197\u2013203","journal-title":"Biol Psychiatry"},{"issue":"1","key":"14_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/metabo8010011","volume":"8","author":"Pollen Yeung","year":"2018","unstructured":"Yeung PK (2018) Metabolomics and biomarkers for drug discovery. Metabolites 8(1)","journal-title":"Metabolites"},{"key":"14_CR6","first-page":"27","volume-title":"Advances in Biological Psychiatry","author":"Simone Lista","year":"2014","unstructured":"Lista S, Giegling I, Rujescu D (2014) Schizophrenia: blood-serum-plasma metabolomics. In: Martins-de-Souza D (ed) Proteomics and metabolomics in psychiatry. Karger Publishers, Basel, p 27\u201344. ISBN-10: 3318025992"},{"issue":"8","key":"14_CR7","doi-asserted-by":"publisher","first-page":"e327","DOI":"10.1371\/journal.pmed.0030327","volume":"3","author":"Elaine Holmes","year":"2006","unstructured":"Holmes E, Tsang TM, Huang JT-J, Leweke FM, Koethe D, Gerth CW et al (2006) Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia. PLoS Med 3(8):e327. https:\/\/doi.org\/10.1371\/journal.pmed.0030327","journal-title":"PLoS Medicine"},{"issue":"8","key":"14_CR8","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1038\/tp.2012.76","volume":"2","author":"Y He","year":"2012","unstructured":"He Y, Yu Z, Giegling I, Xie L, Hartmann AM, Prehn C, Adamski J et\u00a0al (2012) Schizophrenia shows a unique metabolomics signature in plasma. Transl Psychiatry 2:e149. https:\/\/doi.org\/10.1038\/tp.2012.76","journal-title":"Translational Psychiatry"},{"issue":"4","key":"14_CR9","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s11306-013-0508-y","volume":"9","author":"P Zheng","year":"2013","unstructured":"Zheng P, Wei Y-D, Yao G-E, Ren G-P, Guo J, Zhou C-J et al (2013) Novel urinary biomarkers for diagnosing bipolar disorder. Metabolomics 9(4):800\u2013808","journal-title":"Metabolomics"},{"issue":"8","key":"14_CR10","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1021\/acs.jproteome.5b00434","volume":"14","author":"J-J Chen","year":"2015","unstructured":"Chen J-J, Zhou C-J, Liu Z, Fu Y-Y, Zheng P, Yang D-Y et al (2015) Divergent urinary metabolic phenotypes between major depressive disorder and bipolar disorder identified by a combined GC-MS and NMR spectroscopic metabonomic approach. J Proteome Res 14(8):3382\u20133389","journal-title":"J Proteome Res"},{"issue":"3","key":"14_CR11","doi-asserted-by":"publisher","first-page":"pyv096","DOI":"10.1093\/ijnp\/pyv096","volume":"19","author":"Sumit Sethi","year":"2015","unstructured":"Sethi S, Brietzke E (2015) Omics-based biomarkers: application of metabolomics in neuropsychiatric disorders. Int J Neuropsychopharmacol 19(3):yv096. https:\/\/doi.org\/10.1093\/ijnp\/pyv096","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"17","key":"14_CR12","doi-asserted-by":"publisher","first-page":"384A","DOI":"10.1021\/ac031386+","volume":"75","author":"JC Lindon","year":"2003","unstructured":"Lindon JC, Holmes E, Nicholson JK (2003) Peer reviewed: so what\u2019s the deal with metabonomics? Anal Chem 75(17):384A\u2013391A","journal-title":"Anal Chem"},{"key":"14_CR13","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/00005053-196212000-00008","volume":"135","author":"AJ Friedhoff","year":"1962","unstructured":"Friedhoff AJ, van Winkle E (1962) The characteristics of an amine found in urine of schizophrenic patients. J Nerv Ment Dis 135:550\u2013555","journal-title":"J Nerv Ment Dis"},{"key":"14_CR14","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/215132a0","volume":"215","author":"AA Boulton","year":"1967","unstructured":"Boulton AA, Pollitt RJ, Majer JR (1967) Identity of a urinary \u201cpink spot\u201d in schizophrenia and Parkinson\u2019s disease. Nature 215:132\u2013134","journal-title":"Nature"},{"key":"14_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4172\/2153-0769.1000117","volume":"3","author":"TT Money","year":"2013","unstructured":"Money TT, Bousman CA (2013) Metabolomics of psychotic disorders. Metabolomics 3:117. https:\/\/doi.org\/10.4172\/2153-0769.1000117","journal-title":"Metabolomics"},{"key":"14_CR16","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/j.ejps.2017.05.018","volume":"109S","author":"I Kohler","year":"2017","unstructured":"Kohler I, Hankemeier T, van der Graaf PH, Knibbe CAJ, van Hasselt JGC (2017) Integrating clinical metabolomics-based biomarker discovery and clinical pharmacology to enable precision medicine. Eur J Pharm Sci 109S:S15\u2013S21","journal-title":"Eur J Pharm Sci"},{"key":"14_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.copbio.2014.08.006","volume":"31","author":"T Fuhrer","year":"2015","unstructured":"Fuhrer T, Zamboni N (2015) High-throughput discovery metabolomics. Curr Opin Biotechnol 31:73\u201378","journal-title":"Curr Opin Biotechnol"},{"issue":"2","key":"14_CR18","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1039\/C1AN15605E","volume":"137","author":"A Zhang","year":"2012","unstructured":"Zhang A, Sun H, Wang P, Han Y, Wang X (2012) Modern analytical techniques in metabolomics analysis. Analyst 137(2):293\u2013300","journal-title":"Analyst"},{"key":"14_CR19","doi-asserted-by":"crossref","unstructured":"Alonso A, Marsal S, Juli\u00e0 A (2015) Analytical methods in untargeted metabolomics: state of the art in 2015. Front Bioeng Biotechnol 3:23. https:\/\/doi.org\/10.3389\/fbioe.2015.00023","DOI":"10.3389\/fbioe.2015.00023"},{"key":"14_CR20","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.12688\/f1000research.11495.1","volume":"6","author":"Eli Riekeberg","year":"2017","unstructured":"Riekeberg E, Powers R (2017) New frontiers in metabolomics: from measurement to insight. F1000Res 6:1148. https:\/\/doi.org\/10.12688\/f1000research.11495.1","journal-title":"F1000Research"},{"issue":"1","key":"14_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0169-7439(87)80084-9","volume":"2","author":"S Wold","year":"1987","unstructured":"Wold S, Esbensen K, Geladi P (1987) Principal component analysis. Chemometrics Intellig Lab Syst 2(1):37\u201352","journal-title":"Chemometrics Intellig Lab Syst"},{"issue":"9","key":"14_CR22","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1039\/C3AY41907J","volume":"6","author":"R Bro","year":"2014","unstructured":"Bro R, Smilde AK (2014) Principal component analysis. Anal Methods 6(9):2812\u20132831","journal-title":"Anal Methods"},{"issue":"8-10","key":"14_CR23","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/cem.1006","volume":"20","author":"M Bylesj\u00f6","year":"2006","unstructured":"Bylesj\u00f6 M, Rantalainen M, Cloarec O, Nicholson JK, Holmes E, Trygg J (2006) OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification. J Chemom 20(8-10):341\u2013351","journal-title":"J Chemom"},{"issue":"1-2","key":"14_CR24","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.chroma.2007.05.024","volume":"1158","author":"LA Berrueta","year":"2007","unstructured":"Berrueta LA, Alonso-Salces RM, H\u00e9berger K (2007) Supervised pattern recognition in food analysis. J Chromatogr A 1158(1-2):196\u2013214","journal-title":"J Chromatogr A"},{"issue":"1","key":"14_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/00220670209598786","volume":"96","author":"C-YJ Peng","year":"2002","unstructured":"Peng C-YJ, Lee KL, Ingersoll GM (2002) An introduction to logistic regression analysis and reporting. J Educ Res 96(1):3\u201314","journal-title":"J Educ Res"},{"issue":"3","key":"14_CR26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","volume":"68","author":"KR Merikangas","year":"2011","unstructured":"Merikangas KR, Jin R, He J-P, Kessler RC, Lee S, Sampson NA et al (2011) Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 68(3):241\u2013251","journal-title":"Arch Gen Psychiatry"},{"key":"14_CR27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev.clinpsy.3.022806.091444","volume":"3","author":"RC Kessler","year":"2007","unstructured":"Kessler RC, Merikangas KR, Wang PS (2007) Prevalence, comorbidity, and service utilization for mood disorders in the United States at the beginning of the twenty-first century. Annu Rev Clin Psychol 3:137\u2013158","journal-title":"Annu Rev Clin Psychol"},{"issue":"1","key":"14_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4103\/ijmr.IJMR_1386_16","volume":"145","author":"R Sagar","year":"2017","unstructured":"Sagar R, Pattanayak RD (2017) Potential biomarkers for bipolar disorder: where do we stand? Indian J Med Res 145(1):7\u201316","journal-title":"Indian J Med Res"},{"key":"14_CR29","doi-asserted-by":"publisher","first-page":"18008","DOI":"10.1038\/nrdp.2018.8","volume":"4","author":"E Vieta","year":"2018","unstructured":"Vieta E, Berk M, Schulze TG, Carvalho AF, Suppes T, Calabrese JR et al (2018) Bipolar disorders. Nat Rev Dis Primers 4:18008. https:\/\/doi.org\/10.1038\/nrdp.2018.8","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"14_CR30","first-page":"43","volume":"3","author":"DM Hilty","year":"2006","unstructured":"Hilty DM, Leamon MH, Lim RF, Kelly RH, Hales RE (2006) A review of bipolar disorder in adults. Psychiatry 3(9):43\u201355","journal-title":"Psychiatry"},{"issue":"Suppl2","key":"14_CR31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1399-5618.2009.00706.x","volume":"11","author":"E Shorter","year":"2009","unstructured":"Shorter E (2009) The history of lithium therapy. Bipolar Disord 11(Suppl2):4\u20139","journal-title":"Bipolar Disord"},{"key":"14_CR32","first-page":"265","volume-title":"The psychopharmacologists: interviews by David Healey","author":"A Coppen","year":"1996","unstructured":"Coppen A, Healy D (1996) Biological psychiatry in Britain. In: Healy D (ed) The psychopharmacologists: interviews by David Healey. Chapman and Hall, London, pp 265\u2013286"},{"key":"14_CR33","unstructured":"Marwaha S, Sal N, Bebbington P (2014) Adult psychiatric morbidity survey\u2014bipolar disorder. In: NHS digital. https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/adult-psychiatric-morbidity-survey\/adult-psychiatric-morbidity-survey-survey-of-mental-health-and-wellbeing-england-2014 . Accessed 27 Sep 2018"},{"key":"14_CR34","isbn-type":"print","volume-title":"The global burden of disease","author":"CJL Murray","year":"1996","unstructured":"Murray CJL, Lopez AD (1996) The global burden of disease. Harvard University Press, Cambridge, MA. ISBN:0-9655466-0-8","ISBN":"https:\/\/id.crossref.org\/isbn\/0965546608"},{"issue":"10","key":"14_CR35","doi-asserted-by":"crossref","first-page":"349","DOI":"10.5694\/j.1326-5377.1949.tb36912.x","volume":"2","author":"JFJ Cade","year":"1949","unstructured":"Cade JFJ (1949) Lithium salts in the treatment of psychotic excitement. Med J Aust 2(10):349\u2013352","journal-title":"Med J Aust"},{"issue":"2","key":"14_CR36","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s40263-013-0039-0","volume":"27","author":"GS Malhi","year":"2013","unstructured":"Malhi GS, Tanious M, Das P, Coulston CM, Berk M (2013) Potential mechanisms of action of lithium in bipolar disorder. CNS Drugs 27(2):135\u2013153","journal-title":"CNS Drugs"},{"key":"14_CR37","doi-asserted-by":"crossref","unstructured":"Sethi S, Pedrini M, Rizzo LB, Zeni-Graiff M, Mas CD, Cassinelli AC et al (2017) 1H-NMR T2-edited, and 2D-NMR in bipolar disorder metabolic profiling. Int J Bipolar Disord 5(1):23. https:\/\/doi.org\/10.1186\/s40345-017-0088-2","DOI":"10.1186\/s40345-017-0088-2"},{"key":"14_CR38","doi-asserted-by":"publisher","first-page":"5855","DOI":"10.1038\/srep05855","volume":"4","author":"J-J Chen","year":"2014","unstructured":"Chen J-J, Liu Z, Fan S-H, Yang D-Y, Zheng P, Shao W-H et al (2014) Combined application of NMR- and GC-MS-based metabonomics yields a superior urinary biomarker panel for bipolar disorder. Sci Rep 4:5855. https:\/\/doi.org\/10.1038\/srep05855","journal-title":"Sci Rep"},{"issue":"23","key":"14_CR39","doi-asserted-by":"publisher","first-page":"9755","DOI":"10.1021\/ac901502j","volume":"81","author":"A Sussulini","year":"2009","unstructured":"Sussulini A, Prando A, Maretto DA, Poppi RJ, Tasic L, Banzato CEM et al (2009) Metabolic profiling of human blood serum from treated patients with bipolar disorder employing 1H NMR spectroscopy and chemometrics. Anal Chem 81(23):9755\u20139763","journal-title":"Anal Chem"},{"issue":"9","key":"14_CR40","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1039\/C4MB00157E","volume":"10","author":"M-L Liu","year":"2014","unstructured":"Liu M-L, Zheng P, Liu Z, Xu Y, Mu J, Guo J et\u00a0al (2014) GC-MS based metabolomics identification of possible novel biomarkers for schizophrenia in peripheral blood mononuclear cells. Mol BioSyst 10(9):2398\u20132406","journal-title":"Mol BioSyst"},{"issue":"4","key":"14_CR41","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1039\/c3mb70614a","volume":"10","author":"X-J Xu","year":"2014","unstructured":"Xu X-J, Zheng P, Ren G-P, Liu M-L, Mu J, Guo J et\u00a0al (2014) 2,4-Dihydroxypyrimidine is a potential urinary metabolite biomarker for diagnosing bipolar disorder. Mol Biosyst 10(4):813\u2013819","journal-title":"Mol Biosyst"},{"issue":"12","key":"14_CR42","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/j.euroneuro.2015.09.020","volume":"25","author":"MG Soeiro-de-Souza","year":"2015","unstructured":"Soeiro-de-Souza MG, Henning A, Machado-Vieira R, Moreno RA, Pastorello BF, da Costa LC et al (2015) Anterior cingulate Glutamate-Glutamine cycle metabolites are altered in euthymic bipolar I disorder. Eur Neuropsychopharmacol 25(12):2221\u20132229","journal-title":"Eur Neuropsychopharmacol"},{"issue":"12","key":"14_CR43","first-page":"985","volume":"3","author":"Marcio Gerhardt Soeiro-de-Souza","year":"2018","unstructured":"Soeiro-de-Souza MG, Otaduy MCG, Machado-Vieira R, Moreno RA, Nery FG, Leite C et al (2018) Anterior cingulate cortex glutamatergic metabolites and mood stabilizers in euthymic bipolar I disorder patients: a proton magnetic resonance spectroscopy study. Biol Psychiatry Cogn Neurosci Neuroimaging\u00a03(12):985-991","journal-title":"Biological Psychiatry: Cognitive Neuroscience and Neuroimaging"},{"key":"14_CR44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jad.2018.04.010","volume":"235","author":"M\u0130 Atag\u00fcn","year":"2018","unstructured":"Atag\u00fcn M\u0130, \u015e\u0131ko\u011flu EM, Can SS, U\u011furlu GK, Kaymak SU, \u00c7ayk\u00f6yl\u00fc A et al (2018) Neurochemical differences between bipolar disorder type I and II in superior temporal cortices: a proton magnetic resonance spectroscopy study. J Affect Disord 235:15\u201319","journal-title":"J Affect Disord"},{"issue":"12","key":"14_CR45","doi-asserted-by":"publisher","first-page":"e115221","DOI":"10.1371\/journal.pone.0115221","volume":"9","author":"Jian-jun Chen","year":"2014","unstructured":"Chen J-J, Huang H, Zhao L-B, Zhou D-Z, Yang Y-T, Zheng P et al (2014) Sex-specific urinary biomarkers for diagnosing bipolar disorder. PLoS One 9(12):e115221. https:\/\/doi.org\/10.1371\/journal.pone.0115221","journal-title":"PLoS ONE"},{"key":"14_CR46","unstructured":"Haarman BCM, Riemersma-Van der Lek RF (2016) Volume, metabolites and neuroinflammation of the hippocampus in bipolar disorder. Bipolar Disord 56:21\u201333"},{"issue":"9","key":"14_CR47","doi-asserted-by":"publisher","first-page":"S263","DOI":"10.1016\/j.biopsych.2018.02.678","volume":"83","author":"Jonika Tannous","year":"2018","unstructured":"Tannous J, Cao B, Stanley J, Amaral-Silva H, Soares J (2018) Metabolite abnormalities in the anterior white matter of patients with pediatric bipolar disorder. Biol Psychiatry 83(9, Supplement):S263. https:\/\/doi.org\/10.1016\/j.biopsych.2018.02.678","journal-title":"Biological Psychiatry"},{"key":"14_CR48","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.bbacli.2016.03.008","volume":"5","author":"N Yoshimi","year":"2016","unstructured":"Yoshimi N, Futamura T, Kakumoto K, Salehi AM, Sellgren CM, Holm\u00e9n-Larsson J et\u00a0al (2016) Blood metabolomics analysis identifies abnormalities in the citric acid cycle, urea cycle, and amino acid metabolism in bipolar disorder. BBA Clin 5:151\u2013158","journal-title":"BBA Clin"},{"key":"14_CR49","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neulet.2016.11.051","volume":"637","author":"M\u0130 Atag\u00fcn","year":"2017","unstructured":"Atag\u00fcn M\u0130, \u015e\u0131ko\u011flu EM, Soykan \u00c7, Serdar S\u00fcleyman C, Ulusoy-Kaymak S, \u00c7ayk\u00f6yl\u00fc A et al (2017) Perisylvian GABA levels in schizophrenia and bipolar disorder. Neurosci Lett 637:70\u201374","journal-title":"Neurosci Lett"},{"issue":"2","key":"14_CR50","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/pcn.12461","volume":"71","author":"Y Kageyama","year":"2017","unstructured":"Kageyama Y, Kasahara T, Morishita H, Mataga N, Deguchi Y, Tani M et al (2017) Search for plasma biomarkers in drug-free patients with bipolar disorder and schizophrenia using metabolome analysis. Psychiatry Clin Neurosci 71(2):115\u2013123","journal-title":"Psychiatry Clin Neurosci"},{"issue":"2","key":"14_CR51","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00406-016-0731-4","volume":"268","author":"S Poletti","year":"2018","unstructured":"Poletti S, Myint AM, Sch\u00fcetze G, Bollettini I, Mazza E, Grillitsch D et al (2018) Kynurenine pathway and white matter microstructure in bipolar disorder. Eur Arch Psychiatry Clin Neurosci 268(2):157\u2013168","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"11","key":"14_CR52","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1038\/mp.2015.217","volume":"21","author":"N Yoshimi","year":"2016","unstructured":"Yoshimi N, Futamura T, Bergen SE, Iwayama Y, Ishima T, Sellgren C et al (2016) Cerebrospinal fluid metabolomics identifies a key role of isocitrate dehydrogenase in bipolar disorder: evidence in support of mitochondrial dysfunction hypothesis. Mol Psychiatry 21(11):1504\u20131510","journal-title":"Mol Psychiatry"},{"issue":"4","key":"14_CR53","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0893-133X(00)00207-4","volume":"24","author":"P Davanzo","year":"2001","unstructured":"Davanzo P, Thomas MA, Yue K, Oshiro T, Belin T, Strober M et al (2001) Decreased anterior cingulate myo-inositol\/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder. Neuropsychopharmacology 24(4):359\u2013369","journal-title":"Neuropsychopharmacology"},{"key":"14_CR54","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.psychres.2017.08.039","volume":"258","author":"HC Ribeiro","year":"2017","unstructured":"Ribeiro HC, Klassen A, Pedrini M, Carvalho MS, Rizzo LB, Noto MN et al (2017) A preliminary study of bipolar disorder type I by mass spectrometry-based serum lipidomics. Psychiatry Res 258:268\u2013273","journal-title":"Psychiatry Res"},{"key":"14_CR55","doi-asserted-by":"crossref","unstructured":"Liu M-L, Zhang X-T, Du X-Y, Fang Z, Liu Z, Xu Y et al (2015) Severe disturbance of glucose metabolism in peripheral blood mononuclear cells of schizophrenia patients: a targeted metabolomic study. J Transl Med 13:226. https:\/\/doi.org\/10.1186\/s12967-015-0540-y","DOI":"10.1186\/s12967-015-0540-y"},{"issue":"2","key":"14_CR56","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/0006-8993(93)90916-B","volume":"613","author":"John R. Atack","year":"1993","unstructured":"Atack JR, Rapoport SI, Varley CL (1993) Characterization of inositol monophosphatase in human cerebrospinal fluid. Brain Res 613(2):305\u2013308","journal-title":"Brain Research"},{"issue":"6410","key":"14_CR57","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/361315a0","volume":"361","author":"MJ Berridge","year":"1993","unstructured":"Berridge MJ (1993) Inositol trisphosphate and calcium signalling. Nature 361(6410):315\u2013325","journal-title":"Nature"},{"issue":"7","key":"14_CR58","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1001\/archpsyc.1995.03950190013003","volume":"52","author":"HK Manji","year":"1995","unstructured":"Manji HK, Potter WZ, Lenox RH (1995) Signal transduction pathways. Molecular targets for lithium\u2019s actions. Arch Gen Psychiatry 52(7):531\u2013543","journal-title":"Arch Gen Psychiatry"},{"issue":"9","key":"14_CR59","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.biopsych.2010.06.016","volume":"68","author":"C Y\u00fcksel","year":"2010","unstructured":"Y\u00fcksel C, \u00d6ng\u00fcr D (2010) Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders. Biol Psychiatry 68(9):785\u2013794","journal-title":"Biol Psychiatry"},{"issue":"3","key":"14_CR60","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1471-4159.2006.03913.x","volume":"98","author":"LK Bak","year":"2006","unstructured":"Bak LK, Schousboe A, Waagepetersen HS (2006) The glutamate\/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J Neurochem 98(3):641\u2013653","journal-title":"J Neurochem"},{"issue":"4","key":"14_CR61","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0301-0082(90)90013-7","volume":"35","author":"M Ereci\u0144ska","year":"1990","unstructured":"Ereci\u0144ska M, Silver IA (1990) Metabolism and role of glutamate in mammalian brain. Prog Neurobiol 35(4):245\u2013296","journal-title":"Prog Neurobiol"},{"issue":"Suppl 1","key":"14_CR62","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1399-5618.2007.00454.x","volume":"9","author":"BN Frey","year":"2007","unstructured":"Frey BN, Stanley JA, Nery FG, Monkul ES, Nicoletti MA, Chen H-H et al (2007) Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication-free individuals with bipolar disorder: an in vivo 1H MRS study. Bipolar Disord 9(Suppl 1):119\u2013127","journal-title":"Bipolar Disord"},{"key":"14_CR63","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jad.2013.11.004","volume":"155","author":"V Oertel-Kn\u00f6chel","year":"2014","unstructured":"Oertel-Kn\u00f6chel V, Reinke B, Alves G, Jurcoane A, Wenzler S, Prvulovic D et al (2014) Frontal white matter alterations are associated with executive cognitive function in euthymic bipolar patients. J Affect Disord 155:223\u2013233","journal-title":"J Affect Disord"},{"issue":"7-8","key":"14_CR64","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/j.1399-5618.2011.00958.x","volume":"13","author":"LH Lu","year":"2011","unstructured":"Lu LH, Zhou XJ, Keedy SK, Reilly JL, Sweeney JA (2011) White matter microstructure in untreated first episode bipolar disorder with psychosis: comparison with schizophrenia. Bipolar Disord 13(7-8):604\u2013613","journal-title":"Bipolar Disord"},{"issue":"4","key":"14_CR65","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.biopsych.2010.07.028","volume":"69","author":"F Benedetti","year":"2011","unstructured":"Benedetti F, Yeh P-H, Bellani M, Radaelli D, Nicoletti MA, Poletti S et al (2011) Disruption of white matter integrity in bipolar depression as a possible structural marker of illness. Biol Psychiatry 69(4):309\u2013317","journal-title":"Biol Psychiatry"},{"issue":"9","key":"14_CR66","first-page":"638","volume":"39","author":"KR Patel","year":"2014","unstructured":"Patel KR, Cherian J, Gohil K, Atkinson D (2014) Schizophrenia: overview and treatment options. PT 39(9):638\u2013645","journal-title":"PT"},{"issue":"10039","key":"14_CR67","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0140-6736(15)01121-6","volume":"388","author":"MJ Owen","year":"2016","unstructured":"Owen MJ, Sawa A, Mortensen PB (2016) Schizophrenia. Lancet 388(10039):86\u201397","journal-title":"Lancet"},{"key":"14_CR68","doi-asserted-by":"crossref","unstructured":"Kahn RS, Sommer IE, Murray RM, Meyer-Lindenberg A, Weinberger DR, Cannon TD et al (2015) Schizophrenia. Nat Rev Dis Primers 1:15067.\u00a0 https:\/\/doi.org\/10.1038\/nrdp.2015.67","DOI":"10.1038\/nrdp.2015.67"},{"key":"14_CR69","unstructured":"Lavretsky H (2008) History of schizophrenia as a psychiatric disorder. In: Mueser KT, Jeste DV (eds) Clinical handbook of schizophrenia. Guilford Publications, New York, pp 3\u201313. ISBN:9781609182373"},{"key":"14_CR70","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","volume":"20","author":"JD Jentsch","year":"1999","unstructured":"Jentsch JD, Roth RH (1999) The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20:201\u2013225","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"14_CR71","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/gm233","volume":"3","author":"Matej Ore\u0161i\u010d","year":"2011","unstructured":"Ore\u0161i\u010d M, Tang J, Sepp\u00e4nen-Laakso T, Mattila I, Saarni SE, Saarni SI et al (2011) Metabolome in schizophrenia and other psychotic disorders: a general population-based study. Genome Med 3(3):19. https:\/\/doi.org\/10.1186\/gm233","journal-title":"Genome Medicine"},{"issue":"1","key":"14_CR72","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/mp.2011.131","volume":"18","author":"J Yang","year":"2013","unstructured":"Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K et al (2013) Potential metabolite markers of schizophrenia. Mol Psychiatry 18(1):67\u201378","journal-title":"Mol Psychiatry"},{"issue":"6","key":"14_CR73","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1001\/archpsyc.60.6.572","volume":"60","author":"K Hashimoto","year":"2003","unstructured":"Hashimoto K, Fukushima T, Shimizu E, Komatsu N, Watanabe H, Shinoda N et al (2003) Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. Arch Gen Psychiatry 60(6):572\u2013576","journal-title":"Arch Gen Psychiatry"},{"issue":"1-3","key":"14_CR74","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.schres.2007.06.012","volume":"95","author":"A Palomino","year":"2007","unstructured":"Palomino A, Gonz\u00e1lez-Pinto A, Aldama A, Gonz\u00e1lez-G\u00f3mez C, Mosquera F, Gonz\u00e1lez-Garc\u00eda G et al (2007) Decreased levels of plasma glutamate in patients with first-episode schizophrenia and bipolar disorder. Schizophr Res 95(1-3):174\u2013178","journal-title":"Schizophr Res"},{"issue":"2","key":"14_CR75","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0920-9964(94)00034-6","volume":"14","author":"GD Prell","year":"1995","unstructured":"Prell GD, Green JP, Kaufmann CA, Khandelwal JK, Morrishow AM, Kirch DG et al (1995) Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms. Schizophr Res 14(2):93\u2013104","journal-title":"Schizophr Res"},{"issue":"12","key":"14_CR76","doi-asserted-by":"publisher","first-page":"5433","DOI":"10.1021\/pr2006796","volume":"10","author":"J Xuan","year":"2011","unstructured":"Xuan J, Pan G, Qiu Y, Yang L, Su M, Liu Y et al (2011) Metabolomic profiling to identify potential serum biomarkers for schizophrenia and risperidone action. J Proteome Res 10(12):5433\u20135443","journal-title":"J Proteome Res"},{"issue":"1","key":"14_CR77","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ab.2009.09.015","volume":"396","author":"H-L Cai","year":"2010","unstructured":"Cai H-L, Zhu R-H, Li H-D (2010) Determination of dansylated monoamine and amino acid neurotransmitters and their metabolites in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry. Anal Biochem 396(1):103\u2013111","journal-title":"Anal Biochem"},{"issue":"7","key":"14_CR78","doi-asserted-by":"publisher","first-page":"e101652","DOI":"10.1371\/journal.pone.0101652","volume":"9","author":"Takeshi Fukushima","year":"2014","unstructured":"Fukushima T, Iizuka H, Yokota A, Suzuki T, Ohno C, Kono Y et al (2014) Quantitative analyses of schizophrenia-associated metabolites in serum: serum D-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients. PLoS One 9(7):e101652. https:\/\/doi.org\/10.1371\/journal.pone.0101652","journal-title":"PLoS ONE"},{"issue":"9","key":"14_CR79","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1136\/jcp.46.9.861","volume":"46","author":"M Phillips","year":"1993","unstructured":"Phillips M, Sabas M, Greenberg J (1993) Increased pentane and carbon disulfide in the breath of patients with schizophrenia. J Clin Pathol 46(9):861\u2013864","journal-title":"J Clin Pathol"},{"issue":"Suppl 1","key":"14_CR80","doi-asserted-by":"publisher","first-page":"S111","DOI":"10.1007\/s00702-014-1224-0","volume":"122","author":"K AI Awam","year":"2015","unstructured":"AI Awam K, Hau\u00dfleiter IS, Dudley E, Donev R, Br\u00fcne M, Juckel G et al (2015) Multiplatform metabolome and proteome profiling identifies serum metabolite and protein signatures as prospective biomarkers for schizophrenia. J Neural Transm 122(Suppl 1):S111\u2013S122","journal-title":"J Neural Transm"},{"issue":"5111","key":"14_CR81","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/216190a0","volume":"216","author":"CR Creveling","year":"1967","unstructured":"Creveling CR, Daly JW (1967) Identification of 3,4-dimethoxyphenethylamine from schizophrenic urine by mass spectrometry. Nature 216(5111):190\u2013191","journal-title":"Nature"},{"issue":"01","key":"14_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4236\/ojpsych.2011.11001","volume":"1","author":"BM Ross","year":"2011","unstructured":"Ross BM, Shah S, Peet M (2011) Increased breath ethane and pentane concentrations in currently unmedicated patients with schizophrenia. OJPsych 1(01):1\u20137","journal-title":"OJPsych"},{"issue":"4","key":"14_CR83","doi-asserted-by":"publisher","first-page":"e379","DOI":"10.1038\/tp.2014.19","volume":"4","author":"S Koike","year":"2014","unstructured":"Koike S, Bundo M, Iwamoto K, Suga M, Kuwabara H, Ohashi Y et al (2014) A snapshot of plasma metabolites in first-episode schizophrenia: a capillary electrophoresis time-of-flight mass spectrometry study. Transl Psychiatry 4:e379. https:\/\/doi.org\/10.1038\/tp.2014.19","journal-title":"Translational Psychiatry"},{"issue":"3","key":"14_CR84","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0165-1781(91)90062-T","volume":"37","author":"S Baruah","year":"1991","unstructured":"Baruah S, Waziri R, Hegwood TS, Mallis LM (1991) Plasma serine in schizophrenics and controls measured by gas chromatography-mass spectrometry. Psychiatry Res 37(3):261\u2013270","journal-title":"Psychiatry Res"},{"issue":"3","key":"14_CR85","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s11515-016-1400-8","volume":"11","author":"I Petrovchich","year":"2016","unstructured":"Petrovchich I, Sosinsky A, Konde A, Archibald A, Henderson D, Maletic-Savatic M et al (2016) Metabolomics in schizophrenia and major depressive disorder. Front Biol 11(3):222\u2013231","journal-title":"Front Biol"},{"issue":"6","key":"14_CR86","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1358\/dnp.2004.17.6.829029","volume":"17","author":"C Ito","year":"2004","unstructured":"Ito C (2004) The role of the central histaminergic system on schizophrenia. Drug News Perspect 17(6):383\u2013387","journal-title":"Drug News Perspect"},{"issue":"10","key":"14_CR87","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/sj.mp.4002000","volume":"12","author":"R Kaddurah-Daouk","year":"2007","unstructured":"Kaddurah-Daouk R, McEvoy J, Baillie RA, Lee D, Yao JK, Doraiswamy PM et al (2007) Metabolomic mapping of atypical antipsychotic effects in schizophrenia. Mol Psychiatry 12(10):934\u2013945","journal-title":"Mol Psychiatry"},{"issue":"1-3","key":"14_CR88","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.schres.2010.05.012","volume":"121","author":"JT Kantrowitz","year":"2010","unstructured":"Kantrowitz JT, Malhotra AK, Cornblatt B, Silipo G, Balla A, Suckow RF et al (2010) High dose D-serine in the treatment of schizophrenia. Schizophr Res 121(1-3):125\u2013130","journal-title":"Schizophr Res"},{"issue":"7","key":"14_CR89","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1586\/ern.12.65","volume":"12","author":"EA Nunes","year":"2012","unstructured":"Nunes EA, MacKenzie EM, Rossolatos D, Perez-Parada J, Baker GB, Dursun SM (2012) D-serine and schizophrenia: an update. Expert Rev Neurother 12(7):801\u2013812","journal-title":"Expert Rev Neurother"},{"issue":"15","key":"14_CR90","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.1039\/C4AN00583J","volume":"139","author":"MJ Nunes de Paiva","year":"2014","unstructured":"Nunes de Paiva MJ, Menezes HC, de Lourdes CZ (2014) Sampling and analysis of metabolomes in biological fluids. Analyst 139(15):3683\u20133694","journal-title":"Analyst"},{"key":"14_CR91","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.abb.2015.08.024","volume":"589","author":"N Li","year":"2016","unstructured":"Li N, Song YP, Tang H, Wang Y (2016) Recent developments in sample preparation and data pre-treatment in metabonomics research. Arch Biochem Biophys 589:4\u20139","journal-title":"Arch Biochem Biophys"},{"key":"14_CR92","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1039\/C6AY03102A","volume":"9","author":"JGM Pontes","year":"2017","unstructured":"Pontes JGM, Brasil AJM, Cruz GCF, de Souza RN, Tasic L (2017) NMR-based metabolomics strategies: plants, animals and humans. Anal Methods 9:1078\u20131096","journal-title":"Anal Methods"},{"key":"14_CR93","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.aca.2012.05.049","volume":"750","author":"A Smolinska","year":"2012","unstructured":"Smolinska A, Blanchet L, Buydens LMC, Wijmenga SS (2012) NMR and pattern recognition methods in metabolomics: from data acquisition to biomarker discovery: a review. Anal Chim Acta 750:82\u201397","journal-title":"Anal Chim Acta"},{"issue":"11","key":"14_CR94","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1038\/nprot.2007.376","volume":"2","author":"O Beckonert","year":"2007","unstructured":"Beckonert O, Keun HC, Ebbels TMD, Bundy J, Holmes E, Lindon JC et al (2007) Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc 2(11):2692\u20132703","journal-title":"Nat Protoc"},{"key":"14_CR95","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/978-1-4939-6730-8_24","volume":"1546","author":"JGM Pontes","year":"2017","unstructured":"Pontes JGM, Brasil AJM, Cruz GCF, de Souza RN, Tasic L (2017) 1H NMR metabolomic profiling of human and animal blood serum samples. Methods Mol Biol 1546:275\u2013282","journal-title":"Methods Mol Biol"},{"issue":"2","key":"14_CR96","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1021\/pr0605217","volume":"6","author":"EM Lenz","year":"2007","unstructured":"Lenz EM, Wilson ID (2007) Analytical strategies in metabonomics. J Proteome Res 6(2):443\u2013458","journal-title":"J Proteome Res"},{"key":"14_CR97","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/978-1-4939-7614-0_25","volume":"1735","author":"BS Barbosa","year":"2018","unstructured":"Barbosa BS, Martins LG, Costa TBBC, Cruz G, Tasic L (2018) Qualitative and quantitative NMR approaches in blood serum lipidomics. Methods Mol Biol 1735:365\u2013379","journal-title":"Methods Mol Biol"},{"issue":"9","key":"14_CR98","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1074\/mcp.M110.000877","volume":"9","author":"MP Stoop","year":"2010","unstructured":"Stoop MP, Coulier L, Rosenling T, Shi S, Smolinska AM, Buydens L et al (2010) Quantitative proteomics and metabolomics analysis of normal human cerebrospinal fluid samples. Mol Cell Proteomics 9(9):2063\u20132075","journal-title":"Mol Cell Proteomics"},{"issue":"2","key":"14_CR99","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1093\/pcp\/pcs184","volume":"54","author":"Tetsuya Sakurai","year":"2013","unstructured":"Sakurai T, Yamada Y, Sawada Y, Matsuda F, Akiyama K, Shinozaki K et al (2013) PRIMe update: innovative content for plant metabolomics and integration of gene expression and metabolite accumulation. Plant Cell Physiol 54(2):e5\u2013e5. https:\/\/doi.org\/10.1093\/pcp\/pcs184","journal-title":"Plant and Cell Physiology"},{"issue":"W1","key":"14_CR100","doi-asserted-by":"publisher","first-page":"W486","DOI":"10.1093\/nar\/gky310","volume":"46","author":"J Chong","year":"2018","unstructured":"Chong J, Soufan O, Li C, Caraus I, Li S, Bourque G et al (2018) MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis. Nucleic Acids Res 46(W1):W486\u2013W494","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"14_CR101","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1021\/cb4008937","volume":"9","author":"B Worley","year":"2014","unstructured":"Worley B, Powers R (2014) MVAPACK: a complete data handling package for NMR metabolomics. ACS Chem Biol 9(5):1138\u20131144","journal-title":"ACS Chem Biol"},{"key":"14_CR102","doi-asserted-by":"publisher","first-page":"D608","DOI":"10.1093\/nar\/gkx1089","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart DS, Feunang YD, Marcu A, Guo AC, Liang K, V\u00e1zquez-Fresno R et al (2018) HMDB 4.0: the human metabolome database for 2018. Nucleic Acids Res 46:D608\u2013D617","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"14_CR103","doi-asserted-by":"publisher","first-page":"D402","DOI":"10.1093\/nar\/gkm957","volume":"36","author":"EL Ulrich","year":"2007","unstructured":"Ulrich EL, Akutsu H, Doreleijers JF, Harano Y, Ioannidis YE, Lin J, Livny M, Mading S, Maziuk D, Miller Z, Nakatani E, Schulte CF, Tolmie DE, Kent Wenger R, Yao H, Markley JL (2007) BioMagResBank. Nucleic Acids Res 36(Database issue):D402\u2013D408","journal-title":"Nucleic Acids Res"},{"key":"14_CR104","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nbt0208-162","volume":"26","author":"Q Cui","year":"2008","unstructured":"Cui Q, Lewis IA, Hegeman AD, Anderson ME, Li J, Schulte CF et al (2008) Metabolite identification via the Madison Metabolomics Consortium Database. Nat Biotechnol 26:162\u2013164","journal-title":"Nat Biotechnol"},{"key":"14_CR105","first-page":"28","volume":"1","author":"JJ Ellinger","year":"2012","unstructured":"Ellinger JJ, Chylla RA, Ulrich EL, Markley JL (2012) Databases and software for NMR-based metabolomics. Curr Metabolomics 1:28\u201340","journal-title":"Curr Metabolomics"},{"issue":"8","key":"14_CR106","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1021\/ac900036d","volume":"81","author":"A Lommen","year":"2009","unstructured":"Lommen A (2009) MetAlign: interface-driven, versatile metabolomics tool for hyphenated full-scan mass spectrometry data preprocessing. Anal Chem 81(8):3079\u20133086","journal-title":"Anal Chem"},{"key":"14_CR107","doi-asserted-by":"crossref","unstructured":"Pluskal T, Castillo S, Villar-Briones A, Ore\u0161i\u010d M (2010) MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinformatics 11:395. https:\/\/doi.org\/10.1186\/1471-2105-11-395","DOI":"10.1186\/1471-2105-11-395"},{"issue":"3","key":"14_CR108","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1021\/ac051437y","volume":"78","author":"CA Smith","year":"2006","unstructured":"Smith CA, Want EJ, O'Maille G, Abagyan R, Siuzdak G (2006) XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching and identification. Anal Chem 78(3):779\u2013787","journal-title":"Anal Chem"},{"issue":"3","key":"14_CR109","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1021\/ac0614846","volume":"79","author":"MP Styczynski","year":"2007","unstructured":"Styczynski MP, Moxley JF, Tong LV, Walther JL, Jensen KL, Stephanopoulos GN (2007) Systematic identification of conserved metabolites in GC\/MS data for metabolomics and biomarker discovery. Anal Chem 79(3):966\u2013973","journal-title":"Anal Chem"},{"key":"14_CR110","unstructured":"Chen W, Ma C, Miao A, Pang S, Qi D, Wang W (2017) Chemometric methods for the analysis of graftage-related black tea aroma variation by solid phase mirco-extraction and gas chromatography-mass spectrometry. Agilent Technologies. https:\/\/www.agilent.com\/cs\/library\/applications\/5991-8330EN.pdf"},{"issue":"6","key":"14_CR111","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/BF02192855","volume":"2","author":"M Piotto","year":"1992","unstructured":"Piotto M, Saudek V, Sklen\u00e1\u0159 V (1992) Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J Biomol NMR 2(6):661\u2013665","journal-title":"J Biomol NMR"},{"issue":"1","key":"14_CR112","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1006\/jmre.1998.1405","volume":"132","author":"M Liu","year":"1998","unstructured":"Liu M, Mao X, Ye C, Huang H, Nicholson JK, Lindon JC (1998) Improved WATERGATE pulse sequences for solvent suppression in NMR spectroscopy. J Magn Reson 132(1):125\u2013129","journal-title":"J Magn Reson"},{"key":"14_CR113","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1103\/PhysRev.94.630","volume":"94","author":"HY Carr","year":"1954","unstructured":"Carr HY, Purcell EM (1954) Effects of diffusion on free precession in nuclear magnetic resonance experiments. Phys Rev 94:630\u2013638","journal-title":"Phys Rev"},{"key":"14_CR114","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1063\/1.1716296","volume":"29","author":"S Meiboom","year":"1958","unstructured":"Meiboom S, Gill D (1958) Modified spin-echo method for measuring nuclear relaxation times. Rev Sci Instrum 29:688\u2013691","journal-title":"Rev Sci Instrum"},{"key":"14_CR115","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/978-3-319-47656-8_11","volume":"965","author":"S Sethi","year":"2017","unstructured":"Sethi S, Hayashi MAF, Barbosa BS, Pontes JGM, Tasic L, Brietzke E (2017) Lipidomics, biomarkers, and schizophrenia: a current perspective. Adv Exp Med Biol 965:265\u2013290","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"14_CR116","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1021\/acs.analchem.6b04420","volume":"89","author":"GA Nagana Gowda","year":"2017","unstructured":"Nagana Gowda GA, Raftery D (2017) Recent advances in NMR-based metabolomics. Anal Chem 89(1):490\u2013510","journal-title":"Anal Chem"},{"issue":"2","key":"14_CR117","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s11306-014-0704-4","volume":"11","author":"DD Marshall","year":"2015","unstructured":"Marshall DD, Lei S, Worley B, Huang Y, Garcia-Garcia A, Franco R et al (2015) Combining DI-ESI\u2013MS and NMR datasets for metabolic profiling. Metabolomics 11(2):391\u2013402","journal-title":"Metabolomics"},{"issue":"6","key":"14_CR118","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1080\/14737159.2018.1481391","volume":"18","author":"\u00c1 L\u00f3pez-L\u00f3pez","year":"2018","unstructured":"L\u00f3pez-L\u00f3pez \u00c1, L\u00f3pez-Gonz\u00e1lvez \u00c1, Barker-Tejeda TC, Barbas C (2018) A review of validated biomarkers obtained through metabolomics. Expert Rev Mol Diagn 18(6):557\u2013575","journal-title":"Expert Rev Mol Diagn"},{"issue":"7","key":"14_CR119","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1007\/s00216-011-4909-3","volume":"400","author":"J Matsumoto","year":"2011","unstructured":"Matsumoto J, Sugiura Y, Yuki D, Hayasaka T, Goto-Inoue N, Zaima N et al (2011) Abnormal phospholipids distribution in the prefrontal cortex from a patient with schizophrenia revealed by matrix-assisted laser desorption\/ionization imaging mass spectrometry. Anal Bioanal Chem 400(7):1933\u20131943","journal-title":"Anal Bioanal Chem"},{"key":"14_CR120","doi-asserted-by":"publisher","first-page":"3946","DOI":"10.1016\/j.chroma.2010.01.033","volume":"1217","author":"ER Amstalden Van Hove","year":"2010","unstructured":"Amstalden Van Hove ER, Smith DF, Heeren RMA (2010) A concise review of mass spectrometry imaging. J Chromatogr A 1217:3946\u20133954","journal-title":"J Chromatogr A"},{"issue":"1","key":"14_CR121","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/mas.21468","volume":"35","author":"A Bodzon-Kulakowska","year":"2016","unstructured":"Bodzon-Kulakowska A, Sude P (2016) Imaging mass spectrometry: instrumentation, applications, and combination with other visualization techniques. Mass Espectrom Rev 35(1):147\u2013169","journal-title":"Mass Espectrom Rev"}],"container-title":["Advances in Experimental Medicine and Biology","Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-05542-4_14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T13:33:11Z","timestamp":1573911191000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-05542-4_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030055417","9783030055424"],"references-count":121,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-05542-4_14","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"13 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}